文献速递头颈甲状腺与浅表US

超微血管成像评估原发性甲旁亢微波消融疗效的前瞻研究

Superb microvascular imaging for evaluating the efficacy of microwave ablation in primary Hyperparathyroidism: A prospective study.
PubMed 文献 · Eur J Radiol · 2026-06-26

本研究前瞻性纳入57例接受微波消融的原发性甲状旁腺功能亢进患者,于术前及术后1个月行超微血管成像(SMI)检查。以术后SMI结节内无血流信号定义为完全消融,以6个月内血钙维持正常为临床成功。结果显示SMI对预测临床结局具有较高特异度(97.6%)和阳性预测值(91.7%)。

要点

  • 术后1个月SMI若显示结节内仍有血流信号,提示消融不全,临床成功率仅8.3%。
  • SMI判定完全消融者临床成功率达91.1%,可帮助筛选可免于补充治疗的患者。
  • SMI评估消融完全性对预测临床失败具有高特异度(97.6%),但敏感度为73.3%。

核心结论

  • SMI在评估PHPT微波消融完全性及预测6个月临床结局方面显示出良好性能。
  • 术后1个月SMI检出消融不全与临床成功率显著降低独立相关(OR 0.016;95% CI 0.001-0.092;p < 0.001)。
  • 早期发现SMI消融不全有助于识别临床失败高风险患者并支持补充治疗决策。

研究设计与样本

  • 前瞻性研究,纳入2023年9月至2025年1月接受微波消融的57例原发性甲状旁腺功能亢进患者(男性10例,女性47例,平均年龄58.0 ± 11.3岁)。
  • SMI检查分别于消融前及消融后1个月进行,以术后SMI结节内无血管信号定义为完全消融。
  • 临床成功定义为6个月随访期间维持血钙正常。

关键影像表现/征象

  • 术后1个月SMI检出57枚结节中12枚存在结节内血流信号,即消融不全。
  • 12枚消融不全结节中仅1枚(8.3%)获得临床成功;45枚完全消融结节中41枚(91.1%)获得临床成功。

诊断标准与关键数值

  • SMI判定消融完全性预测临床结局:敏感度73.3%,特异度97.6%,阳性预测值91.7%,阴性预测值91.1%。
  • 消融不全独立预测临床成功的比值比为0.016(95% CI 0.001-0.092;p < 0.001)。
  • 完全消融的SMI定义为随访时结节内无血流信号。

临床应用与阅片要点

  • 术后1个月SMI发现结节内残存血流信号时,应警惕临床失败风险,考虑进一步补充消融或其他治疗。
  • SMI具备高特异度,适用于确认消融完全性,减少不必要的重复治疗。
  • SMI敏感度中等(73.3%),SMI显示无血流的结节仍可能有近十分之一临床失败,报告时需结合血钙随访。

局限性

  • 原文未报告样本量计算依据及检验效能分析。
  • 原文未报告SMI操作者间一致性或可重复性评估。
  • 原文未报告消融前后血钙及甲状旁腺激素水平的数值变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the utility of superb microvascular imaging (SMI) for assessing ablation completeness and predicting clinical outcomes after microwave ablation (MWA) in patients with primary hyperparathyroidism (PHPT).

METHODS: This prospective study included 57 patients (10 men, 47 women; mean age, 58.0 ± 11.3 years) who underwent MWA for PHPT between September 2023 and January 2025. SMI examinations were performed before and 1 month after ablation. Complete ablation was defined as the absence of intranodular vascularity on follow-up SMI. Clinical success was defined as maintenance of normocalcemia during the 6-month follow-up.

RESULTS: The clinical success rate was 73.7 %. At 1 month, SMI identified incomplete ablation in 12 of 57 nodules. Clinical success was achieved in 1 of 12 incompletely ablated nodules (8.3 %) compared with 41 of 45 completely ablated nodules (91.1 %). Incomplete ablation was independently associated with reduced odds of clinical success (OR 0.016; 95 % CI 0.001-0.092; p < 0.001). For predicting clinical outcome, SMI-defined ablation completeness yielded a sensitivity of 73.3 %, specificity of 97.6 %, positive predictive value of 91.7 %, and negative predictive value of 91.1 %.

CONCLUSION: SMI showed promising performance in assessing ablation completeness and predicting clinical outcomes after MWA for PHPT. Early detection of incomplete ablation on follow-up SMI may help identify patients at risk for clinical failure and support decisions regarding additional treatment.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Vurgun, Arslan, Alver, et al. Superb microvascular imaging for evaluating the efficacy of microwave ablation in primary Hyperparathyroidism: A prospective study. Eur J Radiol. 2026. PMID: 42372560. doi:10.1016/j.ejrad.2026.113043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。